Unknown NA INTERVENTIONAL 2-arm NCT03606824

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in Patients With Atherosclerotic Cardiovascular Diseases (ThyroHeart-Lipid Study)

Sponsor: Beijing Chao Yang Hospital

Conditions ASCVD Dyslipidemia Statin Subclinical hypothyroïdism

Interventions Pitavastatin and levothyroxine Pitavastatin and placebo

Updated 6 times since 2018 Last updated: Mar 18, 2019 Started: Mar 25, 2019 Primary completion: Feb 28, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03606824, this NA trial focuses on ASCVD and Dyslipidemia and remains ongoing. Sponsored by Beijing Chao Yang Hospital, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Aug 2018 — Apr 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Chao Yang Hospital
Beijing Friendship Hospital
Chinese Academy of Medical Sciences, Fuwai Hospital
Peking University Third Hospital
Shaochun.Li
Xuanwu Hospital, Beijing

Data source: China National Center for Cardiovascular Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China